83866-19-7

Upstream product

• 1147-23-5 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl)-5-iodopyrimidine-2(1H)-one 
• 98-80-6 phenylboronic acid 
• 65-46-3 CYTIDINE 
• 67-56-1 methanol 
• 75-09-2 dichloromethane 
• 21325-49-5 5-phenylcytosine 
• 83866-20-0 C₃₆H₂₉N₃O₈ 

Downstream Products

• 178616-40-5 N-[1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-5-phenyl-1,2-dihydro-pyrimidin-4-yl]-acetamide 
• 178616-31-4 1-(β-D-arabinofuranosyl)-5-phenylcytosine 

Relevant academic research and scientific papers

ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF

The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.

ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF

The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.

Alternative nucleic acid molecules and uses thereof

The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.

Synthesis of 5-phenylcytosine nucleoside derivatives

Reaction of silylated 5-phenylcytosine with 1-O-acetyl-2,3,5-tri-O-benzoyl-D-ribose, catalyzed with tin tetrachloride, and subsequent methanolysis afforded 5-phenylcytidine (2). This compound reacted with thionyl chloride in acetonitrile to give cyclic sulfite 3 which on heating in dimethylformamide was converted into 2,2′-anhydro-1-(β-D-arabinofuranosyl)-5-phenylcytosine (4). Analogous reaction of compound 2 with thionyl chloride at reflux gave 5′-chloro-5′-deoxy-2′,3′-cyclic sulfite 5. Its heating in dimethylformamide afforded 5′-chloro-2,2′-anhydro derivative 6, mild alkaline hydrolysis led to 5′-chloro-5′-deoxy-5-phenylcytidine (7). Alkaline hydrolysis of 5-phenyl-2,2′-anhydrocytidine (4) gave 5-phenylcytosine arabinoside 8, whereas the 2,2′-anhydro derivative 6 afforded 1-(5-chloro-5-deoxy-β-D-arabinofuranosyl)-5-phenylcytosine (11). At higher temperature, the final reaction product was 2,5′-anhydro-5-phenylcytidine(12). 5′-Chloro-5′-deoxynucleosides 7 and 11 reacted with tri-n-butyl-stannane to give 5′-deoxyribofuranosyl and 5′-deoxyarabinofuranosyl derivatives 15 and 16. 5-Phenylcytidine (2) was converted into the N4-acetate 17 with acetic anhydride. Further reaction with acetic anhydride and hydrogen bromide in acetic acid afforded a mixture of peracetylated 2′-bromo and 3′-bromo derivatives 18 and 19. Reaction with Zn/Cu couple gave 5′-O-acetyl-5-phenyl-2′,3′-didehydro derivative 20 and 2′,3′,5′-tri-O-acetyl-5-phenylcytidine (21). Compound 20 was deblocked to 1-(2,3-dideoxy-β-D-glycero-pent-2-enofuranosyl)-5-phenylcytosine (22). Catalytic hydrogenation of compound 20 over palladium and subsequent deblocking of the protected 2′,3′-dideoxy derivative 23 gave 1-(2, 3-dideoxy-β-D-glycero-pentofuranosyl)-5-phenylcytosine (24).

SOME 1-β-D-RIBOFURANOSYL-5-PHENYLCYTOSINES AND -5-(2-CHLOROPHENYL)-2-THIOCYTOSINE

5-Phenylcytidine (XI), 5-(4-nitrophenyl)cytidine (XII) and 5-(2-chlorophenyl)-2-thiocytidine (XIII) were prepared from corresponding trimethylsilyl derivatives V-VII.Nitro derivative XII was converted to amino derivative XIV by catalytic reduction.Cytidines XI-XIV and the starting cytosines I-IV do not display any in vitro inhibitory effect against the influenza virus AWS, virus NDV, vaccinia, herpes simplex and WEE, or in vivo effect on mice infected with the herpes simplex virus type 2 (HSV-2) either.